TY - JOUR KW - Female KW - Humans KW - Male KW - Middle Aged KW - Prospective Studies KW - Cardiovascular Diseases KW - Alcohol Drinking AU - Arima Hisatomi AU - Woodward Mark AU - Grobbee Diederick AU - Weiderpass Elisabete AU - Barrett-Connor Elizabeth AU - Brenner Hermann AU - Shaw Jonathan AU - Kauhanen Jussi AU - Danesh John AU - Smith George AU - Peto Richard AU - Psaty Bruce AU - Sundström Johan AU - Knuiman Matthew AU - Banks Emily AU - Jackson Rod AU - Wareham Nick AU - Boeing Heiner AU - Sattar Naveed AU - Wood Angela AU - Kaptoge Stephen AU - Butterworth Adam AU - Willeit Peter AU - Warnakula Samantha AU - Bolton Thomas AU - Paige Ellie AU - Paul Dirk AU - Sweeting Michael AU - Burgess Stephen AU - Bell Steven AU - Astle William AU - Stevens David AU - Koulman Albert AU - Selmer Randi AU - Verschuren W AU - Sato Shinichi AU - Njølstad Inger AU - Salomaa Veikko AU - Nordestgaard Børge AU - Yeap Bu AU - Fletcher Astrid AU - Melander Olle AU - Kuller Lewis AU - Balkau Beverley AU - Marmot Michael AU - Koenig Wolfgang AU - Casiglia Edoardo AU - Cooper Cyrus AU - Arndt Volker AU - Franco Oscar AU - Wennberg Patrik AU - Gallacher John AU - de la Cámara Agustín AU - Völzke Henry AU - Dahm Christina AU - Dale Caroline AU - Bergmann Manuela AU - Crespo Carlos AU - van der Schouw Yvonne AU - Kaaks Rudolf AU - Simons Leon AU - Lagiou Pagona AU - Schoufour Josje AU - Boer Jolanda AU - Key Timothy AU - Rodriguez Beatriz AU - Moreno-Iribas Conchi AU - Davidson Karina AU - Taylor James AU - Sacerdote Carlotta AU - Wallace Robert AU - J Quiros Ramon AU - Tumino Rosario AU - Blazer Dan AU - Linneberg Allan AU - Daimon Makoto AU - Panico Salvatore AU - Howard Barbara AU - Skeie Guri AU - Strandberg Timo AU - Nietert Paul AU - Kromhout Daan AU - Salamanca-Fernandez Elena AU - Kiechl Stefan AU - Krumholz Harlan AU - Grioni Sara AU - Palli Domenico AU - Huerta José AU - Price Jackie AU - Arriola Larraitz AU - Travis Ruth AU - Panagiotakos Demosthenes AU - Karakatsani Anna AU - Trichopoulou Antonia AU - Kühn Tilman AU - van Schoor Natasja AU - Overvad Kim AU - Langenberg Claudia AU - Forouhi Nita AU - Wennberg Maria AU - Després Jean-Pierre AU - Cushman Mary AU - Cooper Jackie AU - Rodriguez Carlos AU - Sakurai Masaru AU - Voortman Trudy AU - Meisinger Christa AU - Tjønneland Anne AU - Palmieri Luigi AU - Dallongeville Jean AU - Brunner Eric AU - Assmann Gerd AU - Trevisan Maurizio AU - Gillum Richard AU - Ford Ian AU - Lazo Mariana AU - Thompson Simon AU - Ferrari Pietro AU - Leon David AU - Di Angelantonio Emanuele AU - Emerging Risk Factors Collaboration/EPIC-CVD/UK Biobank Alcohol Study Group AB -
BACKGROUND: Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease.
METHODS: We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12·5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5·6 years [5th-95th percentile 1·04-13·5]) from 71 011 participants from 37 studies.
FINDINGS: In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5·4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1·14, 95% CI, 1·10-1·17), coronary disease excluding myocardial infarction (1·06, 1·00-1·11), heart failure (1·09, 1·03-1·15), fatal hypertensive disease (1·24, 1·15-1·33); and fatal aortic aneurysm (1·15, 1·03-1·28). By contrast, increased alcohol consumption was log-linearly associated with a lower risk of myocardial infarction (HR 0·94, 0·91-0·97). In comparison to those who reported drinking >0-≤100 g per week, those who reported drinking >100-≤200 g per week, >200-≤350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1-2 years, or 4-5 years, respectively.
INTERPRETATION: In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines.
FUNDING: UK Medical Research Council, British Heart Foundation, National Institute for Health Research, European Union Framework 7, and European Research Council.
BT - Lancet C1 - https://www.ncbi.nlm.nih.gov/pubmed/29676281?dopt=Abstract DA - 31616108571 DO - 10.1016/S0140-6736(18)30134-X IS - 10129 J2 - Lancet LA - eng N2 -BACKGROUND: Low-risk limits recommended for alcohol consumption vary substantially across different national guidelines. To define thresholds associated with lowest risk for all-cause mortality and cardiovascular disease, we studied individual-participant data from 599 912 current drinkers without previous cardiovascular disease.
METHODS: We did a combined analysis of individual-participant data from three large-scale data sources in 19 high-income countries (the Emerging Risk Factors Collaboration, EPIC-CVD, and the UK Biobank). We characterised dose-response associations and calculated hazard ratios (HRs) per 100 g per week of alcohol (12·5 units per week) across 83 prospective studies, adjusting at least for study or centre, age, sex, smoking, and diabetes. To be eligible for the analysis, participants had to have information recorded about their alcohol consumption amount and status (ie, non-drinker vs current drinker), plus age, sex, history of diabetes and smoking status, at least 1 year of follow-up after baseline, and no baseline history of cardiovascular disease. The main analyses focused on current drinkers, whose baseline alcohol consumption was categorised into eight predefined groups according to the amount in grams consumed per week. We assessed alcohol consumption in relation to all-cause mortality, total cardiovascular disease, and several cardiovascular disease subtypes. We corrected HRs for estimated long-term variability in alcohol consumption using 152 640 serial alcohol assessments obtained some years apart (median interval 5·6 years [5th-95th percentile 1·04-13·5]) from 71 011 participants from 37 studies.
FINDINGS: In the 599 912 current drinkers included in the analysis, we recorded 40 310 deaths and 39 018 incident cardiovascular disease events during 5·4 million person-years of follow-up. For all-cause mortality, we recorded a positive and curvilinear association with the level of alcohol consumption, with the minimum mortality risk around or below 100 g per week. Alcohol consumption was roughly linearly associated with a higher risk of stroke (HR per 100 g per week higher consumption 1·14, 95% CI, 1·10-1·17), coronary disease excluding myocardial infarction (1·06, 1·00-1·11), heart failure (1·09, 1·03-1·15), fatal hypertensive disease (1·24, 1·15-1·33); and fatal aortic aneurysm (1·15, 1·03-1·28). By contrast, increased alcohol consumption was log-linearly associated with a lower risk of myocardial infarction (HR 0·94, 0·91-0·97). In comparison to those who reported drinking >0-≤100 g per week, those who reported drinking >100-≤200 g per week, >200-≤350 g per week, or >350 g per week had lower life expectancy at age 40 years of approximately 6 months, 1-2 years, or 4-5 years, respectively.
INTERPRETATION: In current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week. For cardiovascular disease subtypes other than myocardial infarction, there were no clear risk thresholds below which lower alcohol consumption stopped being associated with lower disease risk. These data support limits for alcohol consumption that are lower than those recommended in most current guidelines.
FUNDING: UK Medical Research Council, British Heart Foundation, National Institute for Health Research, European Union Framework 7, and European Research Council.
PY - 2018 SP - 1513 EP - 1523 T2 - Lancet TI - Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. VL - 391 SN - 1474-547X ER -